TOI and MaxHealth enter full-risk oncology care agreement
Investing.com | Editor Emilio Ghigini
Published Mar 14, 2024 08:24AM ET
CERRITOS, Calif. - The Oncology Institute, Inc. (NASDAQ: TOI), a prominent value-based oncology group, has forged a significant new partnership with MaxHealth, a leader in value-based primary care. The agreement, announced today, involves TOI taking on both clinical and financial responsibility for oncology care across five counties in Florida, including Pinellas, Hillsborough, Polk, Broward, and Miami-Dade.
This full-risk arrangement is designed to integrate seamlessly with MaxHealth's current value-based care agreements with major managed care organizations. Dr. Daniel Virnich, CEO of TOI, expressed enthusiasm about the partnership's potential to enhance the quality of oncology care provided to the community.
TOI employs a model focused on outcomes and quality-based incentives with the aim of improving patient satisfaction and clinical results. This model supports TOI's mission to deliver advanced cancer care within community settings, a move that could potentially transform specialty care delivery.
Dr. Paul Kaplan, Chief Medical Officer of MaxHealth, also welcomed the collaboration, highlighting TOI's commitment to personalized patient care which aligns with MaxHealth's approach to healthcare. The partnership is expected to offer comprehensive cancer care to patients, building on MaxHealth's reputation for coordinated services and patient satisfaction.
The Oncology Institute was established in 2007 and has since been dedicated to providing specialized cancer care in the community. It offers a range of services, including clinical trials and transfusions, typically associated with leading healthcare organizations. With over 110 clinicians and upwards of 70 clinic locations, TOI has been expanding its reach and impact in oncology.
Similarly, MaxHealth operates a network of over 50 primary care facilities throughout Florida, focusing on value-based care and fostering strong provider-patient relationships. This collaboration is indicative of both organizations' commitment to enhancing the patient experience and advancing medical care.
This news article is based on a press release statement from TOI Management, LLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.